Variable | SPKT (n = 42) | KTA (n = 21) | p |
---|---|---|---|
Median follow-up time (years) | 6.74 ± 5.3 | 6.67 ± 2.6 | 0.954 |
Recipient Characteristics | |||
 Age at transplantation (years) | 49.1 ± 4.7 | 51.3 ± 3.2 | 0.789 |
 Male Gender | 28 (66.7%) | 13 (61.9%) | 0.709 |
 Duration of diabetes (years) | 28.6 ± 7.3 | 27.1 ± 6.1 | 0.671 |
 Type of diabetes | |||
  type 1 | 29 (69%) | 12 (57%) | 0.173 |
  type 2 | 13 (21%) | 9 (33%) |  |
Living kidney donation | Â | 7 (33.3%) | - |
Dialysis pretransplant | 38 (90%) | 19 (90.5%) | 1.0 |
Dialysis duration pretransplant (months) | 34.74 ± 32.2 | 54.8 ± 46.3 | 0.128 |
Waiting time pretransplant (months) | 11.2 ± 2.3 | 15.4 ± 5.3 | 0.378 |
Coronary heart disease | 26 (62%) | 16 (76%) | 0.257 |
 one-vessel coronary artery disease | 13 (31%) | 7 (33%) | 0.848 |
 two-vessel coronary artery disease | 6 (14.3%) | 3 (14.3%) | 0.775 |
 three-vessel coronary artery disease | 6 (14.3%) | 6 (28.6%) | 0.173 |
 coronary stents | 12 (29%) | 9 (42%) | 0.257 |
 Peripheral arterial occlusive disease | 13 (31%) | 8 (38%) | 0.571 |
Pre-transplant amputations | 7 (17%) | 4 (19%) | 0.814 |
Arterial hypertension history (years) | 11,4 ± 7.1 | 16.8 ± 11.1 | 0.208 |
Nicotine abuse | 13 (31%) | 7 (35%) | 0.845 |
Aspirin pretransplant | 17 (42%) | 16 (76%) | 0.01 |
Statin pretransplant | 28 (68%) | 16 (76%) | 0.338 |
Donor Characteristics | |||
 Age (years) | 28.2 ± 11.5 | 50.8 ± 13.5 | ˂0.01 |
 Male donor | 26 (62%) | 9 (43%) | 0.151 |
 Donor BMI | 22.8 ± 2.7 | 24.6 ± 2.92 | 0.09 |
 Donor cardiovascular cause of death | 25 (59%) | 9 (43%) | 0.211 |
 Cardiopulmonary resuscitation | 2 (4.8%) | 1 (4.7%) | 1.0 |
 Diabetes mellitus | 0 (0%) | 1 (4.7%) | 0.139 |
 Arterial hypertension | 4 (9.5%) | 6 (29%) | 0.06 |
 Sodium (mEq/L) | 145.5 ± 1.3 | 147 ± 2.1 | 0.345 |
 Creatinine (ummol/L) | 77 ± 8.2 | 79.2 ± 6.2 | 0.755 |
 Urea (mmmol/L) | 6.3 ± 1.5 | 7.1 ± 2.1 | 0.507 |
 Intensive care unit stay (days) | 3.9 ± 0.9 | 4.6 ± 1.2 | 0.581 |
 Cardiovascular events pretransplant | 10 (23.8%) | 10 (47.6%) | 0.06 |
  myocardial infarction | 3 (7.1%) | 5 (23.8%) | 0.06 |
  percutaneous coronary intervention | 4 (9.5%) | 3 (14.2%) | 0.571 |
  coronary artery bypass graft | 3 (7.1%) | 2 (9.5%) | 0.741 |
 Cardiovascular events posttransplant | 3 (7%) | 5 (23%) | 0.05 |
  myocardial infarction | 2 (4.7%) | 2 (10%) | 0.464 |
  percutaneous coronary intervention | 1 (2.3%) | 3 (13%) | 0.067 |
  coronary artery bypass graft | 0 | 0 | 1.0 |
 Cerebrovascular accident pretransplant | 2 (4.8%) | 2 (9.5%) | 0.465 |
 Cerebrovascular accident posttransplant | 1 (2.4%) | 3 (14.3%) | 0.06 |
 Death | 9 (21%) | 9 (42.8%) | 0.08 |
 Cardiovascular cause of death | 3 (7.1%) | 3 (14.2%) | 0.363 |